17/02/2017 A postdoctoral opportunity is immediately available within the Genetic Epidemiology Group to work on multidisciplinary cancer studies. Successful candidates should have a strong background in cancer genomics and/or epidemiology and/or biostatistics, as well as a good command of English. Read more
15/02/2017 The International Agency for Research on Cancer (IARC) is releasing the latest data on the incidence of childhood cancer across the world to mark International Childhood Cancer Day. The results, which are part of the third volume of the International Incidence of Childhood Cancer (IICC) project, are based on collaboration of more than 300 high-quality registries in 82 countries, departments, and territories on five continents. Tabulated data on more than 770 000 neoplasms diagnosed in patients younger than 20 years are now accessible online, with statistics presented for the diagnostic groups relevant to childhood cancer. Visit the website, Read more
10/02/2017 The International Agency for Research on Cancer (IARC) is proud to announce that IARC researchers are part of a team that has been awarded a grant of up to £20 million as part of the Grand Challenge, facilitated by Cancer Research UK. The research project, "Mutographs of Cancer: Discovering the causes of cancer through mutational signatures", is a joint initiative that aims to better define what causes DNA damage and how it leads to cancer. The project is a response to Grand Challenge 3: "Discover how unusual patterns of mutation are induced by different cancer-causing events". Read more
Affordable vaccines key to scale up HPV vaccination and prevent thousands of avoidable cervical cancers
02/02/2017 Read more
WHO/IARC Classification of Tumours, 4th Edition, Volume 9: WHO Classification of Head and Neck Tumours
The WHO Classification of Head and Neck Tumours is the ninth volume in the 4th Edition of the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies evaluating response to therapy and clinical outcome.
Diagnostic criteria, pathological features, and associated genetic alterations are described in a disease-oriented manner. Sections on all recognized neoplasms and their variants include new ICD-O codes, epidemiology, clinical features, macroscopy, pathology, genetics, and prognosis and predictive factors.